Skip to content

Randomised controlled trial of an internet intervention to reduce psychostimulant use

Brief online intervention aimed at psychostimulant users, measuring change in psychostimulant use.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000947909
Enrollment
160
Registered
2011-09-02
Start date
2011-10-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Many Psychostimulant users do not seek treatment for their drug use. Several barriers to treatment have been identified including confidentiality: stigma, socio-demographic factors: employment (particularly full-time employment), gender, and immigrant status, which suggest both physical and cultural barriers to accessing treatment. This study will evaluate the effectiveness of an on-line intervention which uses cognitive behavioural therapy and motivational techniques designed to reduce harmful psychostimulant use.

Interventions

The intervention condition involves an online intervention consisting of motivational interviewing and cognitive behavioural therapy. The intervention is three modules (one to be completed each week). Each module takes approximately 30 minutes. There is no additional routine support (information for external crisis support e.g. help lines will be listed).

Sponsors

The Australian National University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Use of illicit psychostimulants (e.g. meth/amphetamine, ecstasy, non-medical use of prescription psychostimulants) in the last three months; willing to be randomised to one of two study groups; access to the Internet; access to e-mail; informed consent

Exclusion criteria

Currently receiving pharmacotherapy (e.g. methadone, naltrexone, buprenorphine) for any substance use disorder except nicotine replacement therapy; currently receiving any treatment for psychostimulant abuse/dependence; current or past diagnosis of schizophrenia or bipolar disorder.

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 26, 2026